BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1707418)

  • 21. Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.
    Lum LG; Joshi ID; Galoforo SC; Abella E; Karanes C; Ratanatharathorn V; Schultz KR; Uberti JP; Sensenbrenner LL; Ledbetter JA
    Bone Marrow Transplant; 1993 Dec; 12(6):565-71. PubMed ID: 8136739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT).
    Nagler A; Rabinowitz R; Rosengolts-Rat J; Condiotti R; Schlesinger M
    J Hematother Stem Cell Res; 2000 Feb; 9(1):63-75. PubMed ID: 10738973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Otheo E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1996 Feb; 106(5):169-73. PubMed ID: 8684015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation.
    Izquierdo M; Balboa MA; Fernández-Rañada JM; Figuera A; Torres A; Iriondo A; López-Botet M
    Clin Exp Immunol; 1990 Oct; 82(1):145-50. PubMed ID: 1698579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
    Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
    Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice.
    Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J
    Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Bone Marrow Transplant; 1994 Feb; 13(2):181-5. PubMed ID: 7515741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD3+, 4+ and/or 8+ T cells and CD3+, 4-, 8- T cells repopulate at different rates after allogeneic bone marrow transplantation.
    Gratama JW; Fibbe WE; Visser JW; Kluin-Nelemans HC; Ginsel LA; Bolhuis RL
    Bone Marrow Transplant; 1989 May; 4(3):291-6. PubMed ID: 2543471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation.
    Sugita K; Nojima Y; Tachibana K; Soiffer RJ; Murray C; Schlossman SF; Ritz J; Morimoto C
    J Clin Invest; 1994 Aug; 94(2):481-8. PubMed ID: 7518837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry.
    Ginaldi L; Farahat N; Matutes E; De Martinis M; Morilla R; Catovsky D
    J Clin Pathol; 1996 Jul; 49(7):539-44. PubMed ID: 8813949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes.
    Kipps TJ; Duffy SF
    J Clin Invest; 1991 Jun; 87(6):2087-96. PubMed ID: 1710233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
    Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for extrathymic development of TNK cells. NK1+ CD3+ cells responsible for acute marrow graft rejection are present in thymus-deficient mice.
    Kikly K; Dennert G
    J Immunol; 1992 Jul; 149(2):403-12. PubMed ID: 1385604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and phenotypical studies of the Leu-4 (CD3)+, Leu-1 (CD5)- T lymphocyte.
    Srour EF; Walker EB; Walker DE; Jansen J
    Clin Exp Immunol; 1988 Jul; 73(1):34-9. PubMed ID: 3048813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual T cell populations in adult murine bone marrow. Prevalence of CD3+CD4-CD8- and alpha beta TCR+NK1.1+ cells.
    Sykes M
    J Immunol; 1990 Nov; 145(10):3209-15. PubMed ID: 1977798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormally expanded CD8+/Leu-7+ lymphocytes persisting in long-term bone marrow-transplanted patients are resting pre-cytotoxic T-lymphocytes.
    Leroy E; Madariaga L; Ben Aribia M; Mishal Z; Theodorou I; Rochant H; Vernant JP; Senik A
    Exp Hematol; 1990 Aug; 18(7):770-4. PubMed ID: 1696205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological modulation of lymphocyte subpopulation in cervical cancer tissue by sizofiran and OK-432.
    Gorai I; Yanagibashi T; Minaguchi H
    Gynecol Oncol; 1992 Feb; 44(2):137-46. PubMed ID: 1371977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node morphology after allogeneic bone marrow transplantation for chronic myeloid leukemia: a histological and immunohistological study focusing on the phenotype of the recovering lymphoid cells.
    Horny HP; Horst HA; Ehninger G; Kaiserling E
    Blut; 1988 Jul; 57(1):31-40. PubMed ID: 3291990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
    Soiffer RJ; Freedman AS; Neuberg D; Fisher DC; Alyea EP; Gribben J; Schlossman RL; Bartlett-Pandite L; Kuhlman C; Murray C; Freeman A; Mauch P; Anderson KC; Nadler LM; Ritz J
    Bone Marrow Transplant; 1998 Jun; 21(12):1177-81. PubMed ID: 9674848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.